Gene · 5378
Papers1,886
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
721 to 740 of 1,886
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Spectrum of germline cancer susceptibility gene mutations in Turkish colorectal cancer patients: a single center study | Turk J Med Sci | 2020 | 32283892 | PubTator, text mining | PubMed |
| Immunotherapy in Metastatic Colorectal Cancer: Could the Latest Developments Hold the Key to Improving Patient Survival? | Cancers (Basel) | 2020 | 32268531 | PubTator, text mining | PubMed |
| NGS Evaluation of Colorectal Cancer Reveals Interferon Gamma Dependent Expression of Immune Checkpoint Genes and Identification of Novel IFNγ Induced Genes. | Front Immunol | 2020 | 32265897 | PubTator, text mining | PubMed |
| A Genome-Wide Screen for Genes Affecting Spontaneous Direct-Repeat Recombination in Saccharomyces cerevisiae. | G3 (Bethesda) | 2020 | 32265288 | PubTator, text mining | PubMed |
| PreMSIm: An R package for predicting microsatellite instability from the expression profiling of a gene panel in cancer. | Comput Struct Biotechnol J | 2020 | 32257050 | PubTator, text mining | PubMed |
| The roles of curcumin in regulating the tumor immunosuppressive microenvironment. | Oncol Lett | 2020 | 32256807 | PubTator, text mining | PubMed |
| Exome sequencing of familial high-grade serous ovarian carcinoma reveals heterogeneity for rare candidate susceptibility genes. | Nat Commun | 2020 | 32242007 | PubTator, text mining | PubMed |
| Immunotherapy in Glioblastoma: Current Shortcomings and Future Perspectives. | Cancers (Basel) | 2020 | 32235752 | PubTator, text mining | PubMed |
| Pulsed low dose-rate irradiation response in isogenic HNSCC cell lines with different radiosensitivity. | Radiol Oncol | 2020 | 32229678 | PubTator, text mining | PubMed |
| Implications of driver genes associated with a high tumor mutation burden identified using next-generation sequencing on immunotherapy in hepatocellular carcinoma. | Oncol Lett | 2020 | 32218826 | PubTator, text mining | PubMed |
| Mesothelioma developing in carriers of inherited genetic mutations. | Transl Lung Cancer Res | 2020 | 32206572 | PubTator, text mining | PubMed |
| MicroRNA (miR) dysregulation during Helicobacter pylori-induced gastric inflammation and cancer development: critical importance of miR-155. | Oncotarget | 2020 | 32206186 | PubTator, text mining | PubMed |
| ecTMB: a robust method to estimate and classify tumor mutational burden. | Sci Rep | 2020 | 32188929 | PubTator, text mining | PubMed |
| Reveals of New Candidate Active Components in Hemerocallis Radix and Its Anti-Depression Action of Mechanism Based on Network Pharmacology Approach. | Int J Mol Sci | 2020 | 32182911 | PubTator, text mining | PubMed |
| Removal of As(III) from Biological Fluids: Mono- versus Dithiolic Ligands. | Chem Res Toxicol | 2020 | 32180400 | PubTator, text mining | PubMed |
| Evaluation of gene expression levels in the diagnosis of lung adenocarcinoma and malignant pleural mesothelioma. | Turk Gogus Kalp Damar Cerrahisi Derg | 2020 | 32175161 | PubTator, text mining | PubMed |
| Nucleosome positioning stability is a modulator of germline mutation rate variation across the human genome. | Nat Commun | 2020 | 32170069 | PubTator, text mining | PubMed |
| Molecular-Clinical Correlation in Pediatric Medulloblastoma: A Cohort Series Study of 52 Cases in Taiwan. | Cancers (Basel) | 2020 | 32168907 | PubTator, text mining | PubMed |
| Tumor mutational burden is associated with poor outcomes in diffuse glioma. | BMC Cancer | 2020 | 32164609 | PubTator, text mining | PubMed |
| Effect of Tumor Location on Clinicopathological and Molecular Markers in Colorectal Cancer in Eastern China Patients: An Analysis of 2,356 Cases. | Front Genet | 2020 | 32161617 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/5378/papers?page=37